REDWOOD CITY, Calif. — Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced it has appointed Dr. Nicolas Roelofs to serve on its Board of Directors. “Nick is a fantastic addition to our board, bringing over 35 years of broad operational and advisory experience with leading […]
The collaboration focuses on offering guidance, mentorship, and access to expertise to the start-ups housed within NSG Biolabs SINGAPORE — NSG BioLabs, Singapore’s largest provider of biotech co-working laboratory and office space, and the Life Science business of Merck Singapore, announce partnership giving biotech start-ups access to resources and expertise to bolster the research and development capabilities of NSG Biolabs’ […]
— Company poised to accelerate revenue growth into high single digits over next three years, enabled by core genomics portfolio — Innovations to enable development of transformative applications using multiomics — Illumina to offer higher quality insights to customers, helping them improve the overall end-to-end workflow experience and lower cost — Delivering double digit to teens non-GAAP […]
BiotageAB (STO:BIOT) (“Biotage”), the leading global separations Company developing intelligent workflow solutions for drug discovery and development through to diagnostics, has today announced the appointment of Frederic Vanderhaegen as Chief Executive Officer, effective September 16th 2024. Mr. Vanderhaegen succeeds Torben Jørgensen, who stepped in as interim CEO in January 2024 and he will now continue […]
Partnership extends access in Asia to Parse’s growing single cell portfolio SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced an agreement with Taipei-based Prisma Biotech to broaden Parse’s reach in Taiwan and across Asia-Pacific. “Biotech, pharma, and academic researchers across Asia are boosting demand for Parse’s Evercode single cell sequencing solutions […]
Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano) announces today that it has expanded its strategic Alliance Agreement with QIAGEN N.V. (HQ: Venlo, The Netherlands; CEO: Thierry Bernard) to deepen their collaboration in genetic testing, including research and development, production, clinical development, and sales-marketing. Sysmex and QIAGEN have built a successful partnership since the initial […]
Phenomenex broadens its “Designed for PFAS” Portfolio with the expansion of the Strata PFAS Solid Phase Extraction (SPE) offerings for Enhanced PFAS Sample Preparation Single and dual formats quickly remove matrix interferences, ensuring better recoveries and detection limits with fewer errors, less solvent use, and cost savings TORRANCE, Calif. — Phenomenex Inc., a global leader in […]
Mr. Field Bian has been appointed as the new Group CEO of TECHCOMP Instrument Limited, effective August 1, 2024. Mr. Bian will be responsible for managing all TECHCOMP companies globally, including subsidiaries in Europe such as Edinburgh Instruments, Scion Instruments, Precisa, Froilabo, Isotopx, and all Techcomp operations in Americans and Asia. Mr. Bian previously held […]
New funds will support ongoing commercial activities in Europe, the U.S and Asia and further enhance the development of a next-generation single-cell cloning platform OXFORD, UK — iotaSciences, the Oxford-based leader in single-cell biology handling solutions has successfully raised an equity round in new growth funding to continue expansion of its pioneering business related to single-cell biology […]
SEATTLE — TwinStrand Biosciences today announced an agreement with Exact Sciences (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, to exclusively license its patent estate in the cell free nucleic acid sequencing space, including its patent portfolios licensed from the University of Washington and the University of Texas Southwestern. The license is related to TwinStrand Duplex Sequencing® error-correction […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
